ropivacaine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JL; Huang, SM; Liu, ST; Wu, ZF | 1 |
| Benedetti, E; Castelli, V; Cimini, A; d'Angelo, M; Giordano, A; Ippoliti, R; Marinangeli, F; Paladini, A; Piroli, A; Varrassi, G; Zis, P | 1 |
2 other study(ies) available for ropivacaine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Apoptosis, Proliferation, and Autophagy Are Involved in Local Anesthetic-Induced Cytotoxicity of Human Breast Cancer Cells.
Topics: Anesthetics, Local; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Female; Humans; Lidocaine; Mastectomy; Ropivacaine; Triple Negative Breast Neoplasms | 2022 |
Local anesthetics counteract cell proliferation and migration of human triple-negative breast cancer and melanoma cells.
Topics: Anesthetics, Local; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Levobupivacaine; Melanoma; Ropivacaine; Signal Transduction; Triple Negative Breast Neoplasms | 2020 |